Authors: Elba, S.; Buongiorno, G.P.; Caruso, M.L.; Noviello, M.R.; Manghisi, O.G.

Source: Current Pharmaceutical Design, Volume 8, Number 11, 1 May 2002 , pp. 1007-1011(5)

Publisher: Bentham Science Publishers

Abstract:

Between 1995 and 1997 we studied 100 patients with hepatocarcinoma (HCC) and cirrhosis. Of these 74 were males and 26 females with a mean age of 66 years. 13% patients were only HbsAg positive, 75% only anti-HCV positive, 6% HbsAg and anti-HCV and the etiology in 6% of cases was alcoholic. Alpha-foetoprotein was >400ng / ml in only 18% of cases and portal thrombosis was present in 12%. Mononodular HCC was observed in 63% of cases (small HCC in only 38%) and in 79% was localized to the right lobe. Of the mononodular types, 70% were shown by echography to be hypoechoic, 6% hysoechoic, 6% hyperechoic and 17% mixed patterns. Histologically, 49% were well-differentiated, 45% moderately-differentiated and 6%poorly-differentiated. No correlation was found between histologic pattern and number of nodules. Welldifferentiated HCC was found in 51% of mononodular types and in 46% of multinodular types. Moderatelydifferentiated HCC was detected in 46% and 43% respectively and poorly-differentiated HCC in 3% and 11%respectively. No correlation was found between number of nodules and the degree of Edmonson.

Keywords: cirrhosis; hepatocarcinoma; absag; alpha; foetoprotein; portal; thrombosis; nodular hcc; echoic

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1381612024607027

Publication date: 2002-05-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Elba, S. ;  Buongiorno, G.P. ;  Caruso, M.L. ;  Noviello, M.R. ;  Manghisi, O.G.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers